Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
Trent has revised the record date for its first 1:2 bonus issue to June 4, 2026, alongside a ₹6 FY26 dividend with record date revised to June 12.
Borosil Renewables climbed nearly 9% intraday after India extended countervailing duty on Malaysian solar glass imports, adding to recent trade actions against cheaper overseas supply.
OECD trimmed India’s FY27 GDP growth estimate to 6.1% and raised inflation to 5.1%, citing global uncertainty and energy prices, signalling a possible Q2 2026 rate hike.
South Korea has moved ahead of India in global equity market value as AI-linked chip stocks rally, while Indian equities face FPI selling and geopolitical-driven risk-off sentiment.
Ashok Leyland shares slipped after strong Q4 FY26 growth as traders booked profits and analysts flagged near-term risks from input costs, diesel prices, demand and financing conditions.
PIB and RBI rejected reports of a $12 billion gold sale, citing unchanged holdings of 880.52 tonnes and a rising gold share in forex reserves.
Indian equities fell over 1% with IT and banks leading declines after fresh US tariff proposals, as rupee weakened and crude prices rose amid Gulf tensions.
Indian benchmarks slid across multiple sessions as US-Iran tensions and volatile crude prices hit risk appetite, alongside a weaker rupee, persistent FII outflows, and sharp IT profit-booking.
Greaves Cotton has scheduled a May 6, 2026 board meeting and 5 pm earnings call to discuss audited Q4 and FY26 results, with dividend consideration also on the agenda.
LTM Ltd slid nearly 7% amid a tech selloff as brokerages issued sharply different views on whether AI can drive the firm’s Lakshya 2031 growth ambitions.
Trent has set June 4, 2026 as the record date for its first 1:2 bonus issue, making June 3 the effective last buying day under T+1 settlement.
Zydus Lifesciences shares slipped after USFDA observations at multiple Gujarat and Baddi sites, though the company said no data integrity issues and pledged quick remediation.
Natco and Lupin secured USFDA approval for Eribulin Injection, alongside a tentative US nod for Erdafitinib and fresh updates on Form 483 observations at key API sites.
Zydus Lifesciences shares fell over 2% after it reported a USFDA warning letter tied to purified talc observations at its Baddi formulations facility, with no disruption expected.
Power Mech Projects reported a ₹266.26 crore KPI-linked O&M contract for a 2x300 MW plant in Butibori, adding to recent Adani and Mumbai Monorail O&M wins.
NMDC shares have rallied in 2026 as iron ore price hikes, firm global benchmarks and volume guidance of 60 mt for FY27 improve near-term earnings visibility.